Skip to main content

Jubilant Pharmova Ltd - Company Analysis

Jubilant Pharmova Ltd is a pharmaceutical company that operates in three segments: specialty pharmaceuticals, contract research and development services, and proprietary novel drugs. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021.


In this blog post, we will analyze the company's share price, financials and stock performance using data from various sources.


Share Price


As of 09-May-2023, the company's share price on NSE was ₹323.85, down by 3.88% from the previous close of ₹311.75. The company has a market capitalization of ₹5,165 Cr and a 52-week low/high of ₹268.8/₹441.


The company's share price has underperformed the S&P BSE Healthcare and S&P BSE Small Cap indices in the past year, falling by 25.09% compared to 1.62% and 8.31% gains for the respective indices.


The company's share price has also underperformed its peers in the pharmaceuticals and drugs sector, such as Divi's Laboratories Ltd, Dr Reddy's Laboratories Ltd and Cipla Ltd, which have gained 29.77%, 14.34% and 9.67% respectively in the past year.


Financials


The company's financial performance has been mixed in the past few years. The company's revenue has declined by 70.56% in the past three years, from ₹3,439 Cr in FY19 to ₹614 Cr in FY22 (TTM). The company's adjusted earnings per share (EPS) has also declined by 21.6% in the past three years, from ₹13.5 in FY19 to ₹4.9 in FY22 (TTM).


The company's return on equity (ROE) has declined from 11% in FY19 to 4.2% in FY22 (TTM), indicating a lower profitability for the shareholders. The company's operating profit margin has also declined from 15.8% in FY19 to -0.1% in FY22 (TTM), indicating a lower operational efficiency.


The company's debt to equity ratio has improved from 0.8 in FY19 to 0.4 in FY22 (TTM), indicating a lower financial leverage and risk. The company's working capital days have also improved from 161 in FY19 to 0 in FY22 (TTM), indicating a better liquidity management.


The company has negative cash flow from operations of -₹3.55 Cr in FY22 (TTM), indicating a poor cash generation from its core business activities.


Stock Analysis


The company's stock is currently trading at a high price to earnings (PE) ratio of 63.17, which is higher than its median PE of 16.95 in the past 10 years. The company's stock is also trading at a high enterprise value to EBITDA (EV/EBITDA) ratio of 46.76, which is higher than its median EV/EBITDA of 9.02 in the past 10 years.


These valuation ratios suggest that the company's stock is somewhat overvalued compared to its past and its peers.


The company's stock price trend is semi strong, which means that it is likely to rise somewhat in the short term. However, this trend may not be sustainable in the long term unless the company improves its financial performance and growth prospects.


Conclusion


Jubilant Pharmova Ltd is a pharmaceutical company that has shown a poor revenue and profit growth, a lower profitability and efficiency, and a negative cash flow from operations in the past few years. The company's stock is somewhat overvalued based on its current valuation ratios and has underperformed its peers and indices in the past year.


Investors may want to wait for a better entry point or look for other opportunities in the sector until the company shows signs of improvement and recovery.


Disclaimer - I am not a registered investment advisor and the view expressed are not investment advice. Please conduct your own research before investing.

Labels:

Comments

Post a Comment

Popular posts from this blog

Review of Wealth Monitor App by Dezerv

If you are looking for a smart and easy way to manage your wealth, you might want to check out the Wealth Monitor app by Dezerv. Dezerv is a fintech company that offers personalized wealth management solutions for high net worth individuals. The Wealth Monitor app is one of their products that aims to help you track your portfolio performance, get insights on your asset allocation, and access expert advice from Dezerv's team of advisors. The app has a sleek and intuitive design that lets you view your portfolio summary, asset allocation, risk profile, and performance history at a glance. You can also drill down into each asset class and see the details of your holdings, such as the current value, returns, fees, and ratings. The app also provides you with personalized recommendations based on your goals, risk appetite, and preferences. You can easily adjust your portfolio allocation, rebalance your assets, or switch to different products with a few taps. One of the best features of ...
Post a Comment
Read more

Book Summary of What I Learned About Investing from Darwin by Pulak Prasad

In this book, Pulak Prasad, a successful investor and entrepreneur, shares his insights on how to apply the principles of evolutionary biology to investing. He argues that investors can learn a lot from Darwin's theory of natural selection, which explains how organisms adapt to changing environments and survive or go extinct. Prasad draws parallels between the biological and financial worlds, and shows how investors can use Darwin's concepts to analyze companies, markets, and trends. He also provides practical advice on how to develop an evolutionary mindset, which he defines as "the ability to constantly observe, learn, and adapt to changing circumstances". Some of the key takeaways from the book are: - Investing is not about predicting the future, but about understanding the present and adapting to it. Prasad advises investors to focus on the facts and evidence, rather than on opinions and forecasts. He also warns against falling prey to cognitive biases, such as co...
Post a Comment
Read more

Review of INDmoney App

If you are looking for a personal finance app that can help you manage your money, investments, and taxes, you might want to check out INDmoney. INDmoney is an app that claims to offer a holistic financial solution for Indians. In this blog post, I will review the features, benefits, and drawbacks of INDmoney app based on my personal experience. Features of INDmoney App INDmoney app has several features that aim to simplify and optimize your financial life. Some of the main features are: - Money Manager: This feature allows you to track your income, expenses, savings, and loans across all your bank accounts, credit cards, wallets, and UPI apps. You can also set budgets, get alerts, and view reports and insights on your spending patterns. - Investment Advisor: This feature helps you to invest in various asset classes such as mutual funds, stocks, bonds, gold, and cryptocurrencies. You can also access curated portfolios, robo-advisory, and personalized recommendations based on your risk ...
Post a Comment
Read more